HoldiPharma targets EGP 7.5bn in revenues in FY2023: Public Enterprises Ministry
Minister seeks to make optimal use of available resources, introduce new products
HoldiPharma targets EGP 21.1bn revenues in FY 2020/21
Complete plan for Nasr Pharmaceutical Chemicals Company to be implemented within two…
HoldiPharma subsidiaries produce 19m packs of COVID-19 drugs over 4 months
The companies produced 1.3m antibiotic drug packs, 14m packs of antipyretic used…
NBE, Holdipharma sign cooperation protocol to finance pharmacies
Bank’s SMEs portfolio amounts to about EGP 64bn, benefiting 74,000 projects, targeting…
Holdipharma targets revenues of EGP 260m in coming fiscal year
Company’s subsidiaries target EGP 16bn of revenues, up by 47.8%
Health Committee to summon HoldiPharma officials to review development plans next week
Medicine shortage has been exacerbated by negligence of domestic medicine production; most…
